Allergan Sales, LLC recalls Blephamide (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10%/0.2% sterile, 3.5 g tube, RX onl
Recalled July 5, 2017 · FDA recall D-0929-2017 · Allergan Sales
Hazard
Failed Impurities/Degradation Specifications: stability testing results did not meet the specification for impurities. · FDA Class II
Units
648 units
Sold at
Nationwide in the US
Description
Failed Impurities/Degradation Specifications: stability testing results did not meet the specification for impurities.
Product
Blephamide (sulfacetamide sodium and prednisolone acetate ophthalmic ointment, USP) 10%/0.2% sterile, 3.5 g tube, RX only, Manufactured by Allergan, Irvine, California, 92612, U.S.A., NDC: 0023-0313-04.
Manufacturer(s)
Allergan Sales, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →